Literature DB >> 30478496

Impact of deprescribing rounds on discharge prescriptions: an interventional trial.

Rachel Edey1,2, Nicholas Edwards3,4, Jonah Von Sychowski5,6, Ajay Bains4, Jim Spence5,6, Dan Martinusen3,4.   

Abstract

Background Successful deprescribing practices are required to address issues associated with polypharmacy but are hindered by minimal interprofessional collaboration, time constraints, concern for negative outcomes, and absence of a systematic and evidence-based approach. Objective Determine the impact of pharmacist-led deprescribing rounds within a clinical teaching unit (CTU) the number of home medications discontinued upon hospital discharge. Setting Canadian tertiary care hospital. Methods Prospective, dual-arm, interventional study conducted in a single centre, from November 23rd, 2015 to August 30th, 2016. All patients ≥ 19 years old admitted under the CTU were considered for enrolment if on medication(s) prior to admission and patients were excluded if not taking any medications. Study arm allocation alternated daily between the two teams. The control arm operated as per standard whereas the intervention arm's pharmacist used a deprescribing guide and medication review to identify medications eligible for discontinuation prior to discussing during daily rounds. Discharge documents communicated medication changes to patient and primary healthcare providers. The study was sufficiently powered. Main outcome measure The difference of number of home medications discontinued at discharge between the intervention and control groups. Results 171 and 187 patients were allocated to the intervention and control arms, respectively. No significant differences of baseline characteristics existed between groups. Main outcome measure results showed that deprescribing rounds resulted in significantly more medications deprescribed compared to control (65% vs. 38%; p = 0.001). The rates of readmission and emergency department visits were reduced in the intervention arm. Conclusions Incorporating deprescribing rounds into routine care led to significantly greater discontinuation of medications without increasing rate of emergency department visits or hospital admissions.Trial registration ISRCTN11751440.

Entities:  

Keywords:  Canada; Clinical medication reviews; Deprescribing; Inappropriate medication use; Interprofessional collaboration; Patient care; Pharmacist; Polypharmacy

Mesh:

Substances:

Year:  2018        PMID: 30478496     DOI: 10.1007/s11096-018-0753-2

Source DB:  PubMed          Journal:  Int J Clin Pharm


  8 in total

1.  Should Hospital Admission Be Used as an Opportunity for Deprescribing in Older Adults?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2020-10-01

2.  Attitudes toward deprescribing for hospital inpatients.

Authors:  Richard Gilpin; Olwen C McDade; Chris Edwards
Journal:  Clin Med (Lond)       Date:  2022-01       Impact factor: 2.659

Review 3.  Recommendations for outcome measurement for deprescribing intervention studies.

Authors:  Elizabeth A Bayliss; Kathleen Albers; Kathy Gleason; Lisa E Pieper; Cynthia M Boyd; Noll L Campbell; Kristine E Ensrud; Shelly L Gray; Amy M Linsky; Derelie Mangin; Lillian Min; Michael W Rich; Michael A Steinman; Justin Turner; Eduard E Vasilevskis; Sascha Dublin
Journal:  J Am Geriatr Soc       Date:  2022-06-01       Impact factor: 7.538

4.  Polypharmacy Increases Risk of Dyspnea Among Adults With Serious, Life-Limiting Diseases.

Authors:  Kathleen M Akgün; Supriya Krishnan; Shelli L Feder; Janet Tate; Jean S Kutner; Kristina Crothers
Journal:  Am J Hosp Palliat Care       Date:  2019-09-24       Impact factor: 2.500

Review 5.  Medication review interventions to reduce hospital readmissions in older people.

Authors:  Lauren Dautzenberg; Lisa Bretagne; Huiberdina L Koek; Sofia Tsokani; Stella Zevgiti; Nicolas Rodondi; Rob J P M Scholten; Anne W Rutjes; Marcello Di Nisio; Renee C M A Raijmann; Marielle Emmelot-Vonk; Emma L M Jennings; Olivia Dalleur; Dimitris Mavridis; Wilma Knol
Journal:  J Am Geriatr Soc       Date:  2021-02-12       Impact factor: 5.562

6.  Complex chronic patients as an emergent group with high risk of intracerebral haemorrhage: an observational cohort study.

Authors:  Blanca Lorman-Carbó; Josep Lluís Clua-Espuny; Eulàlia Muria-Subirats; Juan Ballesta-Ors; Maria Antònia González-Henares; José Fernández-Sáez; Francisco M Martín-Luján
Journal:  BMC Geriatr       Date:  2021-02-05       Impact factor: 3.921

Review 7.  Managing Polypharmacy in Older Adults with Cancer Across Different Healthcare Settings.

Authors:  Andrew Whitman; Paige Erdeljac; Caroline Jones; Nicole Pillarella; Ginah Nightingale
Journal:  Drug Healthc Patient Saf       Date:  2021-04-29

Review 8.  Deprescribing practices in Canada: A scoping review.

Authors:  Mansi Desai; Tanya Park
Journal:  Can Pharm J (Ott)       Date:  2022-08-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.